US FDA Advises Manufacturers To Test For Nitrosamines In All APIs, Drug Products

Guidance is FDA's latest action in response to findings that over time in storage, especially at higher temperatures, levels of the probable carcinogen NDMAincreases in some ingredients, including ranitidine available in OTC heartburn remedies.